Effects of the acute administration of caffeine in patients with schizophrenia

Caffeine, 10 mg/kg, was administered to 13 schizophrenic patients in a double-blind placebo-controlled study of its behavioral effects. Some measures of psychopathology were significantly increased: Brief Psychiatric Rating Scale (BPRS) total, BPRS subscales thought disorder, unusual thought content, and euphoria-activation, and several individual BPRS items. Nurses' Bunney-Hamberg ratings of psychosis and mania, comparing the day before with the day after pharmacological challenge, increased significantly. Compared to placebo, caffeine also produced significant increases of diastolic blood pressure and cortisol. Thus, these findings indicate that caffeine increases arousal and has a psychotogenic effect when administered to schizophrenic patients. The possible roles of various neurotransmitters is discussed with special emphasis on caffeine's actions on dopaminergic and adenosinergic systems.

[1]  T. Crow,et al.  Molecular pathology of schizophrenia: more than one disease process? , 1980, British medical journal.

[2]  M B Achor,et al.  Diet aids, mania, and affective illness. , 1981, The American journal of psychiatry.

[3]  E. Mikkelsen,et al.  Caffeine and schizophrenia. , 1978, The Journal of clinical psychiatry.

[4]  Locomotor activity stimulation in rats produced by dopamine in the nucleus accumbens: potentiation by caffeine , 1975, The Journal of pharmacy and pharmacology.

[5]  Caffeine actions and adenosine. , 1984, Psychopharmacology bulletin.

[6]  R. Post,et al.  Caffeine: relationship to human anxiety, plasma MHPG and cortisol. , 1984, Psychopharmacology bulletin.

[7]  David A. Hamburg,et al.  Methods for Reliable Longitudinal Observation of Behavior: Development of a Method for Systematic Observation of Emotional Behavior on Psychiatric Wards , 1963 .

[8]  B Waldeck,et al.  Some effects of caffeine and aminophylline on the turnover of catecholamines in the brain , 1971, The Journal of pharmacy and pharmacology.

[9]  Margaret C. Mc Manamy,et al.  Caffeine Intoxication: Report of a Case the Symptoms of Which Amounted to a Psychosis , 1936 .

[10]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[11]  R Workman,et al.  Tolerance to the humoral and hemodynamic effects of caffeine in man. , 1981, The Journal of clinical investigation.

[12]  J. Buster,et al.  Radioimmunoassay of Plasma Cortisol , 1972 .

[13]  B. Angrist,et al.  CNS stimulants as tools in the study of schizophrenia , 1984, Trends in Neurosciences.

[14]  D. Charney,et al.  Increased anxiogenic effects of caffeine in panic disorders. , 1985, Archives of general psychiatry.

[15]  D. Hommer,et al.  Preferential effects of caffeine on limbic and cortical dopamine systems , 1988, Biological Psychiatry.

[16]  L. Judd,et al.  Effects of methylphenidate in adult psychiatric inpatients: a preliminary report. , 1984, Psychopharmacology bulletin.

[17]  T. Crow,et al.  The two-syndrome concept: origins and current status. , 1985, Schizophrenia bulletin.

[18]  D. Janowsky,et al.  Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. , 1976, Archives of general psychiatry.

[19]  B De Freitas,et al.  Effects of caffeine in chronic psychiatric patients. , 1979, The American journal of psychiatry.

[20]  R. Post,et al.  Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. , 1984, Archives of general psychiatry.

[21]  E. Verspohl,et al.  Adaptation of blood pressure to continuous heavy coffee drinking in young volunteers. A double-blind crossover study. , 1983, British journal of clinical pharmacology.

[22]  M J Maloney,et al.  Caffeine toxicity as a cause of acute psychosis in anorexia nervosa. , 1984, The Journal of pediatrics.

[23]  D. Janowsky,et al.  Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. , 1973, Archives of general psychiatry.

[24]  D. Charney,et al.  The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms and blood pressure in healthy humans. , 1984, Life sciences.

[25]  T. Crow,et al.  The two-syndrome concept and neuroendocrinology of schizophrenia. , 1986, The Psychiatric clinics of North America.

[26]  S. Snyder,et al.  Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Snyder,et al.  Behavioral and molecular actions of caffeine: focus on adenosine. , 1984 .